FDA Establishes New Advisory Committee on Digital Health Technologies
Please consider nominating a colleague or yourself. The expertise of statisticians, biostatisticians, and data scientists are critical to the issues to be covered by the new committee
Today, the U.S. Food and Drug Administration announced the creation of a new Digital Health Advisory Committee to help the agency explore the complex, scientific and technical issues related to digital health technologies (DHTs), such as artificial intelligence/machine learning (AI/ML), augmented reality, virtual reality, digital therapeutics, wearables, remote patient monitoring and software.
Learn more here: https://www.fda.gov/news-events/press-announcements/fda-establishes-new-advisory-committee-digital-health-technologies.
The required nomination materials are the following:
- Curriculum vitae for each nominee;
- Acknowledgment and Consent Form (Consent Form);
- A written confirmation that the nominee(s) is aware of the nomination (unless self-nominated);
- Letter(s) of recommendation;
- For Consumer Representative applications, include a cover letter that lists consumer or community organizations for which the candidate can demonstrate active participation.
------------------------------
Steve Pierson
Director of Science Policy
American Statistical Association
------------------------------